MetaCap

ADARx Pharmaceuticals Stock Forecast

NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.79-1.37 (-9.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADRX analyst consensus

Consensus (5 analysts)

strong_buy

Avg. price target

$34.25+167.79%

  • Strong buy 2
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $32.00High $38.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

According to 5 Wall Street analysts covering ADARx Pharmaceuticals (2026-11-19), 5 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $34.25, with a high estimate of $38.00 and a low estimate of $32.00. The average target implies upside of 167.8% from the current price of $12.79.

The spread between the highest and lowest targets is 18.8%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ADRX.

Summary generated from market data by MetaCap's automated system. Methodology

Rating distribution

ADARx Pharmaceuticals analyst rating distribution
RatingAnalystsShare
Strong buy240%
Buy360%
Hold00%
Sell00%
Strong sell00%

Ratings as of 2026-11-19.

Price target scenarios

Price targets versus the current price
TargetPricevs. current
Low target$32.00+150.20%
Average target$34.25+167.79%
High target$38.00+197.11%

How analysts view ADARx Pharmaceuticals's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
SRPThold13.33$21.77+63.32%
KLRAstrong_buy11.02$43.00+290.20%
DMRAstrong_buy23.22$46.78+101.46%
NRIXstrong_buy12.85$33.50+160.80%
TYRAstrong_buy20.12$47.45+135.83%
ANABstrong_buy46.63$87.25+87.11%

Related